Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study

Mohamed Attauabi, Johan Burisch, Jakob Benedict Seidelin

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

12 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Inflammatory Bowel Diseases
Vol/bind	27
Udgave nummer	3
Sider (fra-til)	e37-e38
ISSN	1078-0998
DOI	https://doi.org/10.1093/ibd/izaa297
Status	Udgivet - 2021

Adgang til dokumentet

@article{0c5cb77b9fe64b34bc354c22b54f5c4d,

title = "Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study",

keywords = "perianal fistulizing Crohn disease, ustekinumab",

author = "Mohamed Attauabi and Johan Burisch and Seidelin, {Jakob Benedict}",

year = "2021",

doi = "10.1093/ibd/izaa297",

language = "English",

volume = "27",

pages = "e37--e38",

journal = "Inflammatory Bowel Diseases",

issn = "1078-0998",

publisher = "Lippincott Williams & Wilkins",

number = "3",

}

TY - JOUR

T1 - Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease

T2 - A Double-Center Cohort Study

AU - Attauabi, Mohamed

AU - Burisch, Johan

AU - Seidelin, Jakob Benedict

PY - 2021

Y1 - 2021

KW - perianal fistulizing Crohn disease

KW - ustekinumab

U2 - 10.1093/ibd/izaa297

DO - 10.1093/ibd/izaa297

M3 - Comment/debate

C2 - 33200769

AN - SCOPUS:85097191469

SN - 1078-0998

VL - 27

SP - e37-e38

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

IS - 3

ER -